Metagenomi Ownership | Who Owns Metagenomi?
Metagenomi Ownership Summary
Metagenomi is owned by 25.71% institutional investors, 28.27% insiders, and 46.02% retail investors. Marshall wace, llp is the largest institutional shareholder, holding 0% of MGX shares.
MGX Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Metagenomi | 25.71% | 28.27% | 46.02% |
Sector | Healthcare Stocks | 279.18% | 10.62% | -189.80% |
Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Marshall wace, llp | - | - | - |
Ifp advisors | - | - | - |
Jane street group | - | - | - |
Marquette asset management | - | - | - |
Colony group | - | - | - |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Marshall wace, llp | - | - | - |
Ifp advisors | - | - | - |
Jane street group | - | - | - |
Marquette asset management | - | - | - |
Colony group | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Ifp advisors | - | - | -2.00K |
Colony group | - | - | -27.38K |
Jane street group | - | - | -29.76K |
Marshall wace, llp | - | - | -47.92K |
Marquette asset management | - | - | -51.08K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Marquette asset management | - | - | -51.08K |
Marshall wace, llp | - | - | -47.92K |
Jane street group | - | - | -29.76K |
Colony group | - | - | -27.38K |
Ifp advisors | - | - | -2.00K |
Sold Out
Holder | Change |
---|---|
Ifp advisors | -2.00K |
Colony group | -27.38K |
Jane street group | -29.76K |
Marshall wace, llp | -47.92K |
Marquette asset management | -51.08K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 77 | 4.05% | 9,518,264 | -7.46% | 25 | 3.29% | 39 | -25.00% | 19 | 46.15% |
Dec 31, 2024 | 76 | 18.75% | 10,727,379 | -5.09% | 29 | 3.09% | 54 | 25.58% | 13 | 30.00% |
Sep 30, 2024 | 64 | 18.52% | 11,302,616 | -7.27% | 30 | 2.78% | 43 | 43.33% | 10 | -28.57% |
Jun 30, 2024 | 54 | 10.20% | 12,188,463 | -7.86% | 33 | 0.85% | 30 | -38.78% | 14 | - |
Mar 31, 2024 | 49 | - | 13,227,942 | - | 62 | - | 49 | - | - | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jun 06, 2025 | Wein Matthew | See Remarks | Sell | $348.25 |
Jun 06, 2025 | Noonberg Sarah B. | Chief Medical Officer | Sell | $9.17K |
Jun 06, 2025 | Wapnick Pamela | Chief Financial Officer | Sell | $2.76K |
Jun 06, 2025 | Thomas Brian C. | Chief Executive Officer | Sell | $18.87K |
Jun 06, 2025 | Irish Jian | See Remarks | Sell | $11.18K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | - | - |
2024 Q1 | - | - |
MGX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools